Agilent Technologies, Inc. $A Holdings Lowered by Candriam S.C.A.

Candriam S.C.A. lowered its stake in Agilent Technologies, Inc. (NYSE:A – Free Report) by 19.5% during the third quarter, HoldingsChannel.com reports. The firm owned 1,088,839 shares of the medical research company’s stock after selling 263,389 shares during the period. Agilent Technologies makes up about 0.8% of Candriam S.C.A.’s holdings, making the stock its 21st biggest holding. Candriam S.C.A.’s holdings in Agilent Technologies were worth $188,303,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. State Street Corp grew its stake in shares of Agilent Technologies by 0.7% during the second quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock worth $1,710,658,000 after purchasing an additional 89,598 shares during the period. Wellington Management Group LLP increased its holdings in Agilent Technologies by 2.7% in the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after purchasing an additional 198,253 shares during the last quarter. Deutsche Bank AG increased its holdings in Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after purchasing an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after purchasing an additional 2,440,360 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Agilent Technologies by 9.6% in the first quarter. Dimensional Fund Advisors LP now owns 2,108,764 shares of the medical research company’s stock valued at $240,336,000 after buying an additional 185,223 shares during the period.

Analyst Ratings Changes

A has been the topic of a number of recent analyst reports. Rothschild & Co Redburn raised their target price on Agilent Technologies from $160.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. TD Cowen boosted their target price on Agilent Technologies from $180.00 to $196.00 and gave the stock a “buy” rating in a research report on Tuesday, October 13th. Deutsche Bank Aktiengesellschaft initiated coverage on Agilent Technologies in a research note on Monday, October 26th. They issued a “buy” rating and a $190.00 price target for the company. JPMorgan Chase & Co. upped their price target on Agilent Technologies from $190.00 to $195.00 in a research note on Wednesday, October 14th. Finally, UBS Group increased their price target on shares of Agilent Technologies from $165.00 to $180.00 in a research report on Tuesday, October 13th. Eighteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $181.45.

Check Out Our Latest Stock Report on A

Agilent Technologies Trading Up 1.7%

NYSE:A opened at $174.79 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $182.99. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The stock has a market capitalization of $49.28 billion, a PE ratio of 34.41, a price-to-earnings-growth ratio of 2.56 and a beta of 1.24. The business’s 50-day simple moving average is $165.94 and its 200-day simple moving average is $137.20.

Agilent Technologies (NYSE:A – Get Free Report) last posted its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. During the same period in the prior year, the business earned $1.37 EPS. Agilent Technologies’s revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th were issued a $0.2550 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Tuesday, October 6th. Agilent Technologies’s dividend payout ratio is 20.08%.

Insider Buying and Selling at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director owned 4,924 shares of the company’s stock, valued at $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.

The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.

Recommended Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.